BSE Live
Jan 07, 16:01Prev. Close
179.15
Open Price
179.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 07, 15:59Prev. Close
179.27
Open Price
180.59
Bid Price (Qty.)
182.76 (287)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Marksans Pharma (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 40.93 | 38.53 | 38.53 | 36.78 | 36.78 | |
| Total Share Capital | 53.43 | 52.03 | 52.03 | 50.28 | 50.28 | |
| Reserves and Surplus | 304.75 | 107.89 | 57.95 | -239.52 | -92.42 | |
| Total Reserves and Surplus | 304.75 | 107.89 | 57.95 | -239.52 | -92.42 | |
| Total Shareholders Funds | 358.18 | 159.92 | 109.98 | -188.08 | -42.14 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 19.82 | 7.88 | 15.20 | 19.00 | |
| Deferred Tax Liabilities [Net] | 0.50 | 1.87 | 2.22 | 12.59 | 14.96 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 0.50 | 21.68 | 10.10 | 27.79 | 33.97 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 43.52 | 58.06 | 75.31 | 77.18 | 84.33 | |
| Trade Payables | 44.58 | 40.50 | 29.86 | 29.48 | 29.98 | |
| Other Current Liabilities | 39.88 | 73.59 | 75.05 | 294.43 | 298.51 | |
| Short Term Provisions | 40.45 | 22.68 | 9.95 | 5.12 | 2.10 | |
| Total Current Liabilities | 168.43 | 194.83 | 190.17 | 406.22 | 414.91 | |
| Total Capital And Liabilities | 527.11 | 376.43 | 310.25 | 245.93 | 406.74 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 77.72 | 49.39 | 50.29 | 48.96 | 47.81 | |
| Intangible Assets | 12.29 | 17.43 | 22.56 | 27.70 | 137.09 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 90.01 | 66.82 | 72.85 | 76.66 | 184.90 | |
| Non-Current Investments | 67.62 | 67.62 | 67.62 | 23.51 | 67.62 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.83 | 1.50 | 1.20 | 3.95 | 3.70 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 158.45 | 135.93 | 141.67 | 104.12 | 256.22 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 51.03 | 55.61 | 51.32 | 40.25 | 40.01 | |
| Trade Receivables | 124.63 | 112.38 | 91.42 | 74.19 | 72.17 | |
| Cash And Cash Equivalents | 167.54 | 33.37 | 0.41 | 17.58 | 26.24 | |
| Short Term Loans And Advances | 25.46 | 39.14 | 25.43 | 9.78 | 12.08 | |
| OtherCurrentAssets | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| Total Current Assets | 368.66 | 240.50 | 168.57 | 141.81 | 150.52 | |
| Total Assets | 527.11 | 376.43 | 310.25 | 245.93 | 406.74 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 55.51 | 83.81 | 237.03 | 151.53 | 15.78 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 88.55 | 60.03 | 28.89 | 20.20 | 8.92 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 19.95 | 0.60 | 1.20 | 0.21 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 1.05 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 400.43 | 311.70 | 189.02 | 150.41 | 84.38 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 67.62 | 67.62 | 67.62 | 23.51 | 67.62 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
24.11.2025
Marksans Pharma Standalone September 2025 Net Sales at Rs 320.44 crore, up 3.83% Y-o-Y
09.09.2025
Marksans Pharma Standalone June 2025 Net Sales at Rs 319.73 crore, up 25.62% Y-o-Y
20.05.2025
Marksans Pharma Consolidated March 2025 Net Sales at Rs 708.46 crore, up 26.51% Y-o-Y